• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证功能扩散映射(fDMs)作为人类脑胶质瘤细胞密度的生物标志物。

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.

机构信息

Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

J Magn Reson Imaging. 2010 Mar;31(3):538-48. doi: 10.1002/jmri.22068.

DOI:10.1002/jmri.22068
PMID:20187195
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2903058/
Abstract

PURPOSE

To present comprehensive examinations of the assumptions made in functional diffusion map (fDM) analyses and provide a biological basis for fDM classification.

MATERIALS AND METHODS

Sixty-nine patients with gliomas were enrolled in this study. To determine the sensitivity of apparent diffusion coefficients (ADCs) to cellularity, cell density from stereotactic biopsy specimens was correlated with preoperative ADC maps. For definition of ADC thresholds used for fDMs, the 95% confidence intervals (CI) for changes in voxel-wise ADC measurements in normal appearing tissue was analyzed. The sensitivity and specificity to progressing disease was examined using both radiographic and neurological criteria.

RESULTS

Results support the hypothesis that ADC is inversely proportional to cell density with a sensitivity of 1.01 x 10(-7) [mm(2)/s]/[nuclei/mm(2)]. The 95% CI for white matter = 0.25 x 10(-3) mm(2)/s, gray matter = 0.31 x 10(-3) mm(2)/s, a mixture of white and gray matter = 0.40 x 10(-3) mm(2)/s, and a mixture of white matter, gray matter, and cerebrospinal fluid = 0.75 x 10(-3) mm(2)/s. Application of these measurements as ADC thresholds produce varying levels of sensitivity and specificity to disease progression, which were all significantly better than chance.

CONCLUSION

This study suggests fDMs are valid biomarkers for brain tumor cellularity.

摘要

目的

全面检查功能扩散映射(fDM)分析中所做的假设,并为 fDM 分类提供生物学依据。

材料和方法

本研究纳入 69 例脑胶质瘤患者。为了确定表观扩散系数(ADC)对细胞密度的敏感性,对立体定向活检标本中的细胞密度与术前 ADC 图进行了相关性分析。为了确定用于 fDM 的 ADC 阈值,分析了正常组织中体素 ADC 测量值变化的 95%置信区间(CI)。使用影像学和神经学标准检查了疾病进展的敏感性和特异性。

结果

结果支持 ADC 与细胞密度成反比的假设,其敏感性为 1.01 x 10(-7) [mm(2)/s]/[nuclei/mm(2)]。95%CI 为白质= 0.25 x 10(-3) mm(2)/s,灰质= 0.31 x 10(-3) mm(2)/s,白质和灰质混合物= 0.40 x 10(-3) mm(2)/s,白质、灰质和脑脊液混合物= 0.75 x 10(-3) mm(2)/s。这些测量值作为 ADC 阈值的应用产生了不同水平的疾病进展敏感性和特异性,均明显优于随机水平。

结论

本研究表明 fDM 是脑肿瘤细胞密度的有效生物标志物。

相似文献

1
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.验证功能扩散映射(fDMs)作为人类脑胶质瘤细胞密度的生物标志物。
J Magn Reson Imaging. 2010 Mar;31(3):538-48. doi: 10.1002/jmri.22068.
2
Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas.高级别胶质瘤表观扩散系数与分布扩散系数的比较。
J Magn Reson Imaging. 2010 Mar;31(3):531-7. doi: 10.1002/jmri.22070.
3
Longitudinal restriction spectrum imaging is resistant to pseudoresponse in patients with high-grade gliomas treated with bevacizumab.纵向限制谱成像可抵抗贝伐珠单抗治疗的高级别脑胶质瘤患者的假性反应。
AJNR Am J Neuroradiol. 2013 Sep;34(9):1752-1757. doi: 10.3174/ajnr.A3506. Epub 2013 Apr 11.
4
Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab.弥散加权图像的非线性配准提高了贝伐单抗治疗复发性胶质母细胞瘤的功能弥散图谱的临床灵敏度。
Magn Reson Med. 2012 Jan;67(1):237-45. doi: 10.1002/mrm.23003. Epub 2011 Jun 23.
5
Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.体素内不相干运动扩散加权成像分析胶质瘤分级中的扩散与微灌注,并与动脉自旋标记法比较以评估肿瘤灌注
J Magn Reson Imaging. 2016 Sep;44(3):620-32. doi: 10.1002/jmri.25191. Epub 2016 Feb 16.
6
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.使用定量表观扩散系数和质子磁共振波谱成像对脑胶质瘤术前肿瘤分级进行诊断检查性能的测量。
Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.
7
Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.淋巴瘤和胶质母细胞瘤:3T 高 b 值扩散加权磁共振成像评估表观扩散系数的差异。
Eur J Radiol. 2012 Feb;81(2):339-44. doi: 10.1016/j.ejrad.2010.11.005. Epub 2010 Dec 3.
8
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.基于功能梯度扩散映射定义的表观扩散系数特征可预测贝伐珠单抗治疗复发性胶质母细胞瘤的总生存期。
Neuro Oncol. 2011 Oct;13(10):1151-61. doi: 10.1093/neuonc/nor079. Epub 2011 Aug 19.
9
Glioma grading using apparent diffusion coefficient map: application of histogram analysis based on automatic segmentation.基于自动分割的直方图分析在利用表观扩散系数图进行胶质瘤分级中的应用
NMR Biomed. 2014 Sep;27(9):1046-52. doi: 10.1002/nbm.3153. Epub 2014 Jul 7.
10
Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI.利用体素级解胶质瘤生长模型和系列扩散 MRI 对微观肿瘤侵袭和增殖进行空间定量
Magn Reson Med. 2011 Apr;65(4):1131-43. doi: 10.1002/mrm.22688. Epub 2010 Nov 30.

引用本文的文献

1
Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors.利用人脑肿瘤的图像引导活检对基于磁共振成像的肿瘤细胞密度放射组学图谱进行独立组织学验证。
J Neurooncol. 2025 Jun 21. doi: 10.1007/s11060-025-05105-x.
2
Volumetric and diffusion MRI longitudinal patterns in brain metastases after laser interstitial thermal therapy.激光间质热疗后脑转移瘤的容积和扩散磁共振成像纵向模式
Eur Radiol. 2025 Apr 18. doi: 10.1007/s00330-025-11587-0.
3
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response.

本文引用的文献

1
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.磁共振扩散加权成像作为一种癌症生物标志物:共识与建议
Neoplasia. 2009 Feb;11(2):102-25. doi: 10.1593/neo.81328.
2
Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors.在恶性脑肿瘤的扩散张量磁共振成像中,肿瘤核心的分数各向异性与肿瘤细胞密度呈正相关。
Neuroimage. 2008 Oct 15;43(1):29-35. doi: 10.1016/j.neuroimage.2008.06.041. Epub 2008 Jul 11.
3
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
根据已知可预测抗血管内皮生长因子(VEGF)反应良好的扩散磁共振成像(MRI)表型对放化疗后胶质母细胞瘤进行的高级成像特征分析。
J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05019-8.
4
Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.性激素对胶质母细胞瘤的影响:性别差异与神经放射学见解
Life (Basel). 2024 Nov 21;14(12):1523. doi: 10.3390/life14121523.
5
Assessing tumor microstructure with time-dependent diffusion imaging: Considerations and feasibility on clinical MRI and MRI-Linac.利用时间依赖性扩散成像评估肿瘤微观结构:临床MRI和MRI直线加速器的考量与可行性
Med Phys. 2025 Jan;52(1):346-361. doi: 10.1002/mp.17453. Epub 2024 Oct 10.
6
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.在预测人类非强化型胶质瘤的分子亚型方面,扩散加权磁共振成像优于定量T2液体衰减反转恢复序列不匹配。
Neuroradiology. 2024 Dec;66(12):2153-2162. doi: 10.1007/s00234-024-03475-z. Epub 2024 Oct 8.
7
Metabolic Insight into Glioma Heterogeneity: Mapping Whole Exome Sequencing to In Vivo Imaging with Stereotactic Localization and Deep Learning.胶质瘤异质性的代谢洞察:将全外显子组测序与立体定位和深度学习的体内成像相结合
Metabolites. 2024 Jun 16;14(6):337. doi: 10.3390/metabo14060337.
8
Texture analysis of apparent diffusion coefficient maps: can it identify nonresponse to neoadjuvant chemotherapy for additional radiation therapy in rectal cancer patients?表观扩散系数图的纹理分析:它能否识别直肠癌患者对新辅助化疗联合额外放疗的无反应情况?
Gastroenterol Rep (Oxf). 2024 Apr 22;12:goae035. doi: 10.1093/gastro/goae035. eCollection 2024.
9
Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis.中枢神经系统原发性血管炎中的肿瘤样病变:磁共振成像在鉴别诊断中的作用
Diagnostics (Basel). 2024 Mar 14;14(6):618. doi: 10.3390/diagnostics14060618.
10
Brain diffusion MRI biomarkers after oncology treatments.肿瘤治疗后的脑扩散磁共振成像生物标志物
Rep Pract Oncol Radiother. 2024 Feb 16;28(6):823-834. doi: 10.5603/rpor.98728. eCollection 2023.
功能扩散图谱作为高级别胶质瘤的早期影像生物标志物:与传统放射学反应及总生存期的相关性
J Clin Oncol. 2008 Jul 10;26(20):3387-94. doi: 10.1200/JCO.2007.15.2363. Epub 2008 Jun 9.
4
Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T.恶性肾肿瘤:3T磁共振扩散加权成像中表观扩散系数值与细胞密度的相关性
Radiol Med. 2008 Mar;113(2):199-213. doi: 10.1007/s11547-008-0246-9. Epub 2008 Apr 2.
5
Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging.使用扩散、灌注和渗透性磁共振成像对颅内肿瘤对地塞米松的反应进行定量评估。
Magn Reson Imaging. 2007 Apr;25(3):303-10. doi: 10.1016/j.mri.2006.09.002. Epub 2006 Nov 13.
6
Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity.转移性脑肿瘤的扩散加权成像:与组织学类型及肿瘤细胞密度的比较
AJNR Am J Neuroradiol. 2006 Aug;27(7):1419-25.
7
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.功能扩散图谱:一种用于早期预测癌症治疗结果的影像生物标志物。
Neoplasia. 2006 Apr;8(4):259-67. doi: 10.1593/neo.05844.
8
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.评估功能扩散图谱作为高级别胶质瘤进展时间和总生存期的早期生物标志物。
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16759-64. doi: 10.1073/pnas.0508347102. Epub 2005 Nov 2.
9
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.功能扩散图谱:一种用于临床脑肿瘤反应早期分层的非侵入性磁共振成像生物标志物。
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9. doi: 10.1073/pnas.0501532102. Epub 2005 Apr 1.
10
Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans.用于三维容积脑磁共振成像扫描的受试者间配准算法的定量比较。
J Neurosci Methods. 2005 Mar 15;142(1):67-76. doi: 10.1016/j.jneumeth.2004.07.014.